BioSpace News Archive

Press Releases

Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

April 20, 2026
·
1 min read
Press Releases

Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq

April 20, 2026
·
4 min read
Press Releases

Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026

April 20, 2026
·
1 min read
Press Releases

Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition

April 20, 2026
·
8 min read
Press Releases

Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026

April 20, 2026
·
1 min read
Press Releases

Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

April 20, 2026
·
9 min read
Press Releases

Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD

April 20, 2026
·
10 min read
Press Releases

Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond

April 20, 2026
·
7 min read
Press Releases

Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026

April 20, 2026
·
9 min read
Press Releases

Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

April 20, 2026
·
6 min read